Periodontal Diseases — Melatonin as an Adjunctive Therapy for Chronic Periodontitis.
Citation(s)
Armitage GC Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999 Dec;4(1):1-6. Review.
Bhatavadekar NB, Williams RC Modulation of the host inflammatory response in periodontal disease management: exciting new directions. Int Dent J. 2009 Oct;59(5):305-8. Review.
Gulle K, Akpolat M, Kurcer Z, Cengiz MI, Baba F, Acikgoz S Multi-organ injuries caused by lipopolysaccharide-induced periodontal inflammation in rats: role of melatonin. J Periodontal Res. 2014 Dec;49(6):736-41. doi: 10.1111/jre.12156. Epub 2013 Dec 19.
Ito E, Inoue Y [The International Classification of Sleep Disorders, third edition. American Academy of Sleep Medicine. Includes bibliographies and index]. Nihon Rinsho. 2015 Jun;73(6):916-23. Review. Japanese.
Joshi N, Biswas J, Nath C, Singh S Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology. Mol Neurobiol. 2015 Aug;52(1):330-40. doi: 10.1007/s12035-014-8865-8. Epub 2014 Aug 27. Review.
Kantarci A, Van Dyke TE Lipoxin signaling in neutrophils and their role in periodontal disease. Prostaglandins Leukot Essent Fatty Acids. 2005 Sep-Oct;73(3-4):289-99. Review.
Kos M, Kuebler JF, Luczak K, Engelke W Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk. J Craniomaxillofac Surg. 2010 Jun;38(4):255-9. doi: 10.1016/j.jcms.2009.06.005. Epub 2009 Jul 9.
Krayer JW, Leite RS, Kirkwood KL Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases. Dent Clin North Am. 2010 Jan;54(1):13-33. doi: 10.1016/j.cden.2009.08.010. Review.
LOE H, SILNESS J PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. Acta Odontol Scand. 1963 Dec;21:533-51.
Maria S, Witt-Enderby PA Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures. J Pineal Res. 2014 Mar;56(2):115-25. doi: 10.1111/jpi.12116. Epub 2014 Jan 15. Review.
Moreno Villagrana AP, Gómez Clavel JF Antimicrobial or subantimicrobial antibiotic therapy as an adjunct to the nonsurgical periodontal treatment: a meta-analysis. ISRN Dent. 2012;2012:581207. doi: 10.5402/2012/581207. Epub 2012 Oct 22.
Novak MJ, Donley TG Using host response modifiers in the treatment of periodontal disease. Pract Proced Aesthet Dent. 2002 Nov-Dec;14(9):suppl 3-10; quiz 11.
Page RC The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res. 1991 May;26(3 Pt 2):230-42. Review.
SILNESS J, LOE H PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. Acta Odontol Scand. 1964 Feb;22:121-35.
Srinath R, Acharya AB, Thakur SL Salivary and gingival crevicular fluid melatonin in periodontal health and disease. J Periodontol. 2010 Feb;81(2):277-83. doi: 10.1902/jop.2009.090327.
Van Dyke TE, Serhan CN Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res. 2003 Feb;82(2):82-90. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
